Latest Business Expansion News

Ovanti Limited has completed a $1 million capital raise through a discounted share placement to accelerate its buy now, pay later business expansion in the United States.

AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.

Algorae Pharmaceuticals has announced a non-renounceable Loyalty Options Offer to eligible shareholders, aiming to raise up to $337,678 before costs, with potential additional capital of $4.7 million if all options are exercised. The capital raise supports the company’s pharmaceutical and AI research and development ambitions.

Novatti Group has attracted a $1 million investment from Australian Wealth Advisors Group to fuel its renewed growth strategy, focusing on expanding its Acquiring business following positive early financial results.

CONNEQT Health reports robust 50% quarter-on-quarter growth in Pulse device sales and launches a new pricing strategy to boost recurring revenue. The company also secures a significant US clinical trial contract and advances cost-cutting efforts.

Supply Network Limited reported robust FY2025 results with double-digit revenue growth, expanded capacity across Australia and New Zealand, and announced a new auditor appointment at its AGM.

Bank of Queensland’s August 2025 APRA Basel III Pillar 3 report reveals stable capital ratios and robust liquidity metrics, underscoring its disciplined risk management amid portfolio growth.

Ovanti Limited has secured $8 million through a strategic share placement to accelerate its US Buy Now, Pay Later expansion, highlighted by a new three-year NASCAR sponsorship deal.

Stakk Limited has successfully raised $15 million through an oversubscribed equity placement, underscoring strong institutional confidence in its Embedded Finance growth strategy. The funds will accelerate expansion in the U.S. and Australian markets as the company’s recurring revenue surges.

Bod Science Limited has reported a notable profit turnaround for FY2025, driven by medicinal cannabis sales growth, while navigating a complex Deed of Company Arrangement and a proposed backdoor listing with Biortica Agrimed Limited.

Catalyst Metals has doubled its gold Reserves at the Plutonic Belt to 1.5 million ounces, underpinning a bold plan to double annual production to 200,000 ounces over the next decade.

Clime Investment Management Limited has reported a significant turnaround in FY25, returning to profitability with a 13% revenue increase and proposing a fully franked final dividend. The company expanded its business lines and strengthened its leadership team, setting a positive outlook for FY26.